Target intelligence / Profile preview

Pantothenic acid pathway enzymes

Molecular classification
Enzyme
01

Overview

Pantothenic acid pathway enzymes are responsible for the multistep biosynthesis of coenzyme A from pantothenic acid (vitamin B5), requiring ATP and contributing to essential cellular functions such as energy metabolism, fatty acid synthesis, signal transduction, and synthesis of hormones and neurotransmitters. The main enzymes include pantothenate kinase, phosphopantothenoylcysteine synthetase, phosphopantothenoylcysteine decarboxylase, phosphopantetheine adenylyl transferase, and dephosphocoenzyme A kinase. These enzymes are vital in all living organisms, and dysfunction can lead to metabolic and neurodegenerative diseases such as PKAN. For therapeutic targeting and clinical relevance, specific enzymes (most notably pantothenate kinase) are more commonly addressed than the entire pathway as a unit. If "pantothenic acid pathway enzymes" is encountered as a drug target, it is usually necessary to identify the specific enzyme, most often pantothenate kinase (PANK/PANK2), as the explicit target for structured pharmacological or clinical data. The entry here describes the class of enzymes responsible for the conversion of pantothenic acid to coenzyme A, not a single molecular entity.

Other names
Enzymes of the pantothenic acid pathwayCoenzyme A biosynthetic enzymesVitamin B5 metabolic enzymesPantothenate pathway enzymes
02

Mechanism of action

Enzyme activation or inhibition (e.g., increasing CoA synthesis or blocking pathway intermediates); Substrate competition (end-product inhibition by CoA against pantothenate kinase)

03

Biological functions

Coenzyme A biosynthesisCellular energy productionMetabolism of carbohydrates, fats, and proteinsFatty acid synthesisSignal transduction (via acylation and acetylation of proteins)
04

Disease associations

Neurodegenerative disease (e.g., pantothenate kinase-associated neurodegeneration (PKAN))Metabolic disorderOther (due to wide-ranging metabolic importance)
05

Safety considerations

Neurological dysfunction (PKAN) due to enzyme gene mutation (PANK2)Potential disturbances of energy metabolism if pathway is altered
06

Interacting drugs

Dexpanthenol (pro-vitamin B5)

1 more in the full profile.

07

Biomarkers

CoA levels in tissues or bloodUrinary pantothenic acid excretion

Beyond the preview

Go deeper on Pantothenic acid pathway enzymes.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Pantothenic acid pathway enzymes.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call